Skip to content
  • ABOUT
        • MISSION/HISTORY
        • DIRECTORS/STAFF
        • SUPPORT
        • INTERNSHIPS
        • FINANCIAL INFORMATION
        • JOBS
        • CONTACT US
  • WASTEWATCHER
  • MEDIA
        • CONGRESSIONAL RATINGS
        • PORKER OF THE MONTH
        • PRESS RELEASES
        • COMMENTARY
  • ISSUES
    • CONGRESSIONAL PIG BOOK
      • Earmark Database
      • PRIME CUTS
      • ISSUE BRIEFS
      • AGENCY COMMENTS
    • DEFENSE
      • AVIATION & SPACE
      • F-35 JOINT STRIKE FIGHTER
      • PROCUREMENT
    • INNOVATION & TECHNOLOGY POLICY CENTER
      • ANTITRUST
      • ARTIFICIAL INTELLIGENCE
      • BIOPHARMACEUTICALS
      • INTELLECTUAL PROPERTY
      • PRIVACY
      • TECHNOLOGY AND INNOVATION
      • TELECOMMUNICATIONS
    • GENERAL WASTE
      • AGRICULTURE REFORM
      • POSTAL SERVICE
      • TAXES
      • TRANSPORTATION
    • HEALTH AND SCIENCE
      • PRICE CONTROLS
      • GOVERNMENT RUN HEALTHCARE
      • 340B DRUG DISCOUNT PROGRAM
      • PHARMACY BENEFIT MANAGERS
      • TOBACCO HARM REDUCTION
    • STATE ISSUES
  • ITPC
        • ANTITRUST
        • ARTIFICIAL INTELLIGENCE
        • BIOPHARMACEUTICALS
        • INTELLECTUAL PROPERTY
        • PRIVACY
        • TECHNOLOGY AND INNOVATION
        • TELECOMMUNICATIONS
  • CCAGW
DONATE
Facebook X-twitter Icon-instagram-1 Icon-youtube

Pharmaceuticals

What’s Worse than Most Favored Nation – Budget Reconciliation
Biopharmaceuticals, Budget, Entitlements, General Waste, Healthcare, Pharmaceuticals

What’s Worse than Most Favored Nation – Budget Reconciliation

August 10, 2021 Elizabeth Wright

The Biden administration proposes to recind President Trump’s Most Favored Nation Policy.

340B, Biopharmaceuticals, Budget, Congress, General Waste, Healthcare, Pharmaceuticals

Biden Budget Offers Potential Oversight Tool on 340B Program

June 11, 2021 Elizabeth Wright

The Biden administration’s budget includes new enforcement tools for oversight of the 340B program but the details will matter.

General Waste, Healthcare, Intellectual Property, International, Pharmaceuticals, Property Rights

Biden Trips Badly on Intellectual Property in TRIPS

May 7, 2021 Elizabeth Wright

Days after praising World Intellectual Property Day, President Biden agrees to waive US COVID-19 patents.

Most Favored Nation Policy Is Unfavorable to U.S. Biopharmaceutical Research
Biopharmaceuticals, General Waste, Healthcare, Intellectual Property, Pharmaceuticals

Most Favored Nation Policy Is Unfavorable to U.S. Biopharmaceutical Research

November 20, 2020 Elizabeth Wright

Back in September, President Trump signed an Executive Order ordering the Department of Health and Human Services to implement a most favored nation (MFN) policy for pharmaceutical reimbursement in Medicare.

Healthcare, Big Government, Biopharmaceuticals, General Waste, Pharmaceuticals, Property Rights, State Issues, States

CAGW to HHS: Say No to State AGs Demands

August 8, 2020 Elizabeth Wright

On Tuesday, state attorneys general from across the country and two U.S. territories demanded that the federal government steal the patent for remdesivir.

Healthcare, Big Government, Biopharmaceuticals, General Waste, International, Pharmaceuticals

The IPI – Are We All Socialists Now?

February 1, 2020 Elizabeth Wright

Adopting these policies would validate socialized medicine schemes like price controls and rationing.

Healthcare, Biopharmaceuticals, Medicaid, Medicare, Medicare/aid, Pharmaceuticals

CBO Releases the “Savings” Expected from Speaker Pelosi’s Drug Pricing Bill

December 7, 2019 Elizabeth Wright

H.R. 3 exerts so much government authority over the pharmaceutical industry.

Healthcare, CMS, Medicare, Medicare/aid, Pharmaceuticals

Morning Joe Is Wrong: Medicare Does Negotiate Drug Prices

October 12, 2016 Elizabeth Wright

Today on the Morning Joe Show, a false narrative was perpetuated: Medicare does not negotiate drug prices. The show’s eponymous host, Joe Scarborough, called for free-marketers to call Congress and demand that the government negotiate Medicare drug prices. Joe needs to supervise his producers’ research better.  The free market is very much involved in negotiating […]

Biopharmaceuticals, Biosimilars, Budget, General Waste, Healthcare, Obamacare, Pharmaceuticals

Salvage the Good from the Healthcare Debacle

August 1, 2006 Thomas Schatz

The healthcare reform juggernaut, arguably the most radical attempt to remake the economy and the nation’s healthcare infrastructure in history, was supposed to have flown through Congress before the August recess with nary a peep.  Instead, as Americans have gotten wind of its alarming provisions and exorbitant costs, the plan appears to be fizzling fast in the summer heat.

Posts pagination

Previous 1 … 3 4

Search

Citizens Against Government Waste works to eliminate waste, fraud, abuse, and mismanagement in government through research and public education.

  • MISSION/HISTORY
  • DIRRECTORS/STAFF
  • SUPPORT
  • FINANCIAL INFORMATION
  • CONTACT US
  • CCAGW
  • 1-800-USA-DEBT ®
  • MEDIA@CAGW.ORG
  • 317 MASSACHUSETTS AVENUE, N.E.
    SUITE 300
    WASHINGTON, D.C. 20002

© Citizens Against Government Waste